Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-11-21

FDA Approved: INDOMETHACIN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for indomethacin submitted by Chartwell RX, LLC. This action represents an approved supplement to the original NDA, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOMETHACIN (INDOMETHACIN)